https://www.marketscreener.com/quote/stock/REVVITY-INC-12426/news/PerkinElmer-Phase-I-Clinical-Trial-Examines-Safety-of-Using-Cord-Blood-Stem-Cells-for-Treating-Chi-24165858/?utm_source=telegram&utm_medium=social&utm_campaign=share